Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.

Herpes Simplex Labialis Clinical Trial

Official title: Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS (Hansaplast®) Based on Hydrocolloids Without Active Substances in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product (Herpes Vesicle Patch of COMPEED®)

Status Completed

Clinical Trial Summary

Recent clinical studies showed, that a hydrocolloid patch is effective, well tolerated and comparable with aciclovir cream 5 % for the treatment of HSL lesions, while affording additional benefits of wound protection, discretion and relief of social embarrassment. The aim of the actual study was the clinical assessment of the effectiveness and safety of Hansaplast® SOS Herpes Patch (HPHP) in comparison to Compeed® Herpes Vesicle Patch (CHP) in treating HSL. Both products are CE-certificated and are available at the market for medical devices.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

• Herpes Labialis
• Herpes Simplex
• Herpes Simplex Labialis

• NCT number: NCT02157090
• Study type: Interventional
• Source: Technische Universität Dresden
• Status: Completed
• Phase: N/A
• Start date: August 2009
• Completion date: June 2010